OCTOBER 2020: Oncology
October 21, 2020
What’s new in oncology for October 2020? We’ve rounded up information on potential cancer-reducing drugs, liquid biopsy to detect brain tumors, and new immune-like characteristics of cells.
October 12, 2020 / eLife
Cholesterol-lowering drugs called statins may reduce cancer risk in humans through a pathway unrelated to cholesterol, says a study published in eLife.
October 14, 2020 / Massachusetts General
Genetic mutations that promote the growth of the most common type of adult brain tumors can be accurately detected and monitored in blood samples using an enhanced form of liquid biopsy.
October 15, 2020 / Vanderbilt University
Vanderbilt University researchers have reported the counterintuitive discovery that certain chemotherapeutic agents used to treat tumors can have the opposite effect of tissue overgrowth in normal, intact mammary glands, epidermis and hair follicles. The researchers also are the first to report the discovery of an innate immune signaling pathway in fibroblasts—the spindle-shaped cells responsible for wound healing and collagen production—that causes cells to proliferate. Such signaling pathways previously were attributed only to immune cells.
